By Marcia Dunn

Jeff Bezos' rocket company has won a NASA contract to land astronauts on the moon, two years after it lost out to SpaceX.

Blue Origin received a $3.4 billion contract Friday to lead a team to develop a lunar lander named Blue Moon. It will be used to transport astronauts to the lunar surface as early as 2029, following a pair of crew landings by Elon Musk’s SpaceX.

NASA will get astronauts to lunar orbit using its own rockets and capsules, but wants private companies to take over from there.

NASA Administrator Bill Nelson said the agency wants different landing options as it seeks a return to the moon more than a half-century after the end of the Apollo moonshots.

Blue Origin is kicking in billions of dollars, on top of the NASA contract, to help establish a permanent presence on the moon.

“We have a lot to do before we successfully land and return astronauts," said John Couluris, a Blue Origin vice president.

Two years ago, Blue Origin sued after NASA awarded SpaceX the contract for the first lunar landing. A federal judge upheld the space agency’s decision.

NASA’s Artemis program, which follows the 1960s and 1970s Apollo moonshots. kicked off with a successful test flight late last year. Launched atop NASA's new moon rocket, an empty Orion capsule went into lunar orbit before returning home.

The next Artemis flight will come late next year when one Canadian and three U.S. astronauts fly to the moon and back, but not land. Two Americans would descend to the lunar surface aboard a SpaceX Starship on the mission after that, no earlier than late 2025.

Like SpaceX, Blue Origin plans to practice landing on the moon without a crew, before putting astronauts on board.

While the shiny, stainless steel Starship has a science fiction look, Blue Moon resembles more of a traditional capsule perched atop a tall compartment with legs. The latter will stand 52 feet (16 meters) on the moon.

Both companies' landers are meant to be reusable.

Blue Origin will use its still-in-development New Glenn rocket to launch its lunar missions from Cape Canaveral. Starship, the world's largest rocket, made its debut last month from South Texas; the test flight ended in an explosive fireball a few minutes into flight.

Blue Origin's team includes five partners: Lockheed Martin, Boeing, Draper, Astrobotic Technology and Honeybee Robotics.

Only one other bid was submitted for the contract competition, according to NASA.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

Share:
More In Science
Germany Sees New COVID Cases Hit Record High
Countries around the world continue to grapple with rising COVID cases, with Germany confirming case numbers at their highest at any point during the pandemic. German officials say that 48,000 new cases are being reported everyday.
How 'Space Hero' is Democratizing Space Travel
Deborah Sass, CO-CEO and Founding Partner of Space Hero, joins ChedHER to discuss how she's creating a global competition to send someone on a 10-day trip to space, her experience in the space industry without a background in STEM, and how she hopes to inspire younger generations of women.
Verdict Watch, Patient Zero & Love, Hate, Ate
Jill and Carlo are back to cover the latest in the Rittenhouse trial, new information on the origins of Covid, return-to-office and more. JOIN US FOR THE YOUTUBE WATCH PARTY @ 9aET: http://www.youtube.com/cheddarnow
Russia Anti-Satellite Missile Test Blamed For Space Debris
Over the weekend, Russia fired a missile at one of its own satellites, triggering an explosion that launched thousands of pieces of shrapnel through space and forced the astronauts aboard the International Space Station to shelter in place. Senior Writer from Space.com Chelsea 'Foxanne' Gohd, joined Cheddar to discuss more.
U.S. Facing Potential Winter Surge of COVID
Gerald Comissiong, CEO of Todos Medical, joins None of the Above to discuss why we're seeing surges of COVID-19 cases in Europe, the potential for a winter surge of COVID-19, the benefits of high vaccination rates in a community, and the coming COVID treatment pills.
Load More